Defibrillator implantation in patients with nonischemic systolic heart failure

Cited by (999)

Items 101–200 of 999

1. Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure
   Raza M. Alvi, Anne M. Neilan, Noor Tariq, Magid Awadalla, Maryam Afshar, Dahlia Banerji, Adam Rokicki, Connor P. Mulligan, Virginia A. Triant, Markella V. Zanni et al. · 2018 · Journal of the American College of Cardiology
2. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
   Nielsen, Jens Cosedis, Lin, Yenn-Jiang, de Oliveira Figueiredo, Marcio Jansen, Sepehri Shamloo, Alireza, Alfie, Alberto, Boveda, Serge, Dagres, Nikolaos, Di Toro, Dario, Eckhardt, Lee L, Ellenbogen, Kenneth et al. · 2020 · EP Europace
3. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines
   Matthew T. Bennett, Ratika Parkash, Pablo B. Nery, Mario Sénéchal, Blandine A. Mondesert, DAVID H. BIRNIE, Laurence D. Sterns, Claus Rinne, Derek V. Exner, François Philippon et al. · 2016 · Canadian Journal of Cardiology
4. Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease
   Srinivas Rao Dukkipati, Jacob Sam Koruth, Subbarao Choudry, Marc A. Miller, William Whang, Vivek Yerrapu Reddy · 2017 · Journal of the American College of Cardiology
5. Impact of Late Gadolinium Enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: A systematic review and meta-analysis
   Anand Narayan Ganesan, James E. Gunton, Gaetano Nucifora, Andrew D. McGavigan, Joseph Brindaban Selvanayagam · 2018 · International Journal of Cardiology
6. Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
   Giovanni Donato Aquaro, Carmelo De Gori, Lorenzo Faggioni, Maria Luisa Parisella, Dania Cioni, Riccardo Antonio Lencioni, Emanuele Neri · 2023 · European Heart Journal Supplements
7. Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT
   Jeanne E. Poole, Brian Olshansky, Daniel B. Mark, Jill Anderson, George William Johnson, Anne S. Hellkamp, Linda D. Davidson-Ray, Daniel P. Fishbein, Robin Boineau, Kevin Joseph Anstrom et al. · 2020 · Journal of the American College of Cardiology
8. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
   Edmond M. Cronin, Frank Matthias Bogun, Philippe Maury, Petr Peichl, Minglong Chen, Narayanan Namboodiri, Luis Aguinaga, Luiz Roberto Leite, Sana M. Al‐Khatib, Elad Anter et al. · 2020 · Journal of Interventional Cardiac Electrophysiology
9. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis
   Simon A. S. Beggs, Pardeep S. Jhund, Colette E. Jackson, John J.V. McMurray, Roy S. Gardner · 2017 · Heart
10. Contemporary Survival Trends and Aetiological Characterization in Non-Ischaemic Dilated Cardiomyopathy
    Marco Merlo, Antonio Nicola Cannata, Carola Pio Loco Detto Gava, Davide Stolfo, Giulia Barbati, Jessica Artico, Piero Gentile, Valerio De Paris, Federica Ramani, Massimo Zecchin et al. · 2020 · European Journal of Heart Failure
11. Arrhythmias as Presentation of Genetic Cardiomyopathy
    James L. Laws, Megan Cummins Lancaster, M.B. Shoemaker, William G. Stevenson, Rebecca R. Hung, Quinn Stanton Wells, D. Marshall Brinkley, Sean G. Hughes, Katherine C. Anderson, Dan M. Roden et al. · 2022 · Circulation Research
12. Contemporary American and European Guidelines for Heart Failure Management
    John W. Ostrominski, Ersilia M. DeFilippis, Kannu Bansal, Ralph J. Riello, Biykem Bozkurt, Paul A. Heidenreich, Muthiah Vaduganathan · 2024 · JACC Heart Failure
13. Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes
    Aditya Mandawat, Pairoj Chattranukulchai, Anant Mandawat, Alexander J. Blood, Sindhoor Ambati, Brenda D. Hayes, Wolfgang G. Rehwald, Han W. Kim, John F. Heitner, Dipan J. Shah et al. · 2021 · JACC. Cardiovascular imaging
14. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
    Xavier Rosselló, Cono A. Ariti, Stuart Pocock, João Pedro Ferreira, Nicolas Girerd, John J.V. McMurray, Dirk Jan van Veldhuisen, Bertram Pitt, Faiez M. Zannad · 2018 · Clinical Research in Cardiology
15. Impact of Left Ventricular Function and Heart Failure Symptoms on Outcomes Post Ablation of Atrial Fibrillation in Heart Failure
    Christian Sohns, Konstantin Zintl, Yan Daniel Zhao, Lilas Dagher, Dietrich Andresen, Jürgen Siebels, Karl Wegscheider, Susanne Sehner, Lucas V.A. Boersma, Béla Péter Merkely et al. · 2020 · Circulation Arrhythmia and Electrophysiology
16. Risk stratification of sudden cardiac death: a review
    Jacob Tfelt‐Hansen, Rodrigue Garcia, Christine M. Albert, José Luís Merino, Andrew David Krahn, Éloi Marijon, Cristina Basso, Arthur A.M. Wilde, Kristina Hermann Haugaa · 2023 · EP Europace
17. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy
    Francisco Leyva, Abbasin Zegard, Edmund Acquaye, Christopher Gubran, Robin James Taylor, Paul W.X. Foley, Fraz Umar, Kiran Patel, Jonathan R. Panting, Howard J. Marshall et al. · 2017 · Journal of the American College of Cardiology
18. Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation
    Francisco Leyva, Abbasin Zegard, Osita Okafor, Paul W.X. Foley, Fraz Umar, Robin James Taylor, Howard J. Marshall, Berthold Stegemann, William Edward Moody, Richard Paul Steeds et al. · 2022 · Journal of the American College of Cardiology
19. Cardiac Implantable Electronic Devices
    Sana M. Al‐Khatib · 2024 · New England Journal of Medicine
20. Arrhythmic Genotypes in Familial Dilated Cardiomyopathy: Implications for Genetic Testing and Clinical Management
    Stacey A. Peters, Saurabh Kumar, Perry M Elliot, Jonathan M. Kalman, Diane Fatkin · 2018 · Heart Lung and Circulation
21. Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives
    Marco Merlo, Thomas Caiffa, Marco Gobbo, Luigi Adamo, Gianfranco Sinagra · 2018 · IJC Heart & Vasculature
22. Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
    Mohammed Majid Akhtar, Perry M Elliot · 2019 · Current Cardiology Reports
23. Sudden Cardiac Arrest Risk Assessment
    Robert J. Myerburg, Jeffrey J. Goldberger · 2017 · JAMA Cardiology
24. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey
    Kristina Hermann Haugaa, Roland Richard Tilz, Serge Bovéda, Dan Dobreanu, Elena Sciaraffia, Jacques Mansourati, Giorgi Papiashvili, Nikolaos Dagres · 2017 · EP Europace
25. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
    Dmitry S. Lebedev, Evgeny N. Mikhaylov, N. M. Neminuschiy, Elena Zelikovna Golukhova, Vadim E. Babokin, Vera V. Bereznitskaya, Elena S. Vasichkina, S. V. Garkina, Golitsyn Sp, Karapet V. Davtyan et al. · 2021 · Russian Journal of Cardiology
26. Ventricular Arrhythmias and Sudden Cardiac Death
    Pok‐Tin Tang, Mohammad Shenasa, Noel G. Boyle · 2017 · Cardiac Electrophysiology Clinics
27. Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality)
    Adelina Yafasova, Jawad H. Butt, Marie B. Elming, Jens C. Nielsen, Jens Haarbo, Lars Videbæk, Line L. Olesen, Flemming Hald Steffensen, Niels E. Bruun, Hans Eiskjær et al. · 2021 · Circulation
28. Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries
    Christian Sticherling, Barbora Arendacká, Jesper Hastrup Svendsen, Sofieke C. Wijers, Tim Friede, Jochem Stockinger, Michael Dommasch, Béla Péter Merkely, Rik Willems, Andrzej Lubiński et al. · 2017 · EP Europace
29. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators
    Barry J. Maron, Susan A. Casey, Iacopo Olivotto, Mark V. Sherrid, Christopher Semsarian, Camillo Autore, Aisha K. Ahmed, Giuseppe Boriani, Pietro Francia, Stephen L. Winters et al. · 2018 · Circulation Arrhythmia and Electrophysiology
30. Sudden Cardiac Death Substrate Imaged by Magnetic Resonance Imaging
    Kathérine C. Wu · 2017 · Circulation Cardiovascular Imaging
31. Fighting against sudden cardiac death: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention
    Éloi Marijon, Rodrigue Garcia, Kumar Narayanan, Nicole Karam, Xavier Jouven · 2021 · European Heart Journal
32. Heart failure as a substrate and trigger for ventricular tachycardia
    Chikezie Alvarez, Edmond M. Cronin, William L. Baker, Jeffrey Kluger · 2019 · Journal of Interventional Cardiac Electrophysiology
33. Management of Arrhythmias After Heart Transplant
    José A. Joglar, Elaine Y. Wan, Mina K. Chung, Alejandra Gutiérrez, Mark S. Slaughter, Brian P. Bateson, Michael J. Loguidice, Mark H. Drazner, Peter M. Kistler, Basil Saour et al. · 2021 · Circulation Arrhythmia and Electrophysiology
34. An ECG-based artificial intelligence model for assessment of sudden cardiac death risk
    Lauri T. A. Holmström, Harpriya S. Chugh, Kotoka Nakamura, Ziana Bhanji, Madison Seifer, Audrey Uy‐Evanado, Kyndaron Reinier, David Ouyang, Sumeet S. Chugh · 2024 · Communications Medicine
35. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate
    Sérgio Barra, Serge Bovéda, Rui Andre Providencia, Nicolas Sadoul, Rudolf Martin Duehmke, Christian Reitan, Rasmus Borgquist, Kumar Narayanan, Françoise Hidden‐Lucet, Didier Klug et al. · 2017 · Journal of the American College of Cardiology
36. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
    Farah Cadour, Morgane Quemeneur, Loïc Bière, Erwan Donal, Zakarya Bentatou, Jean‐Christophe Eicher, François Roubille, Alain Lalande, Roch Giorgi, Stanislas Rapacchi et al. · 2023 · Journal of Cardiovascular Magnetic Resonance
37. Does the heart transplant have a future?
    Matthias Fuchs, David Schibilsky, Wolfgang Zeh, Michael Berchtold‐Herz, Friedhelm Beyersdorf, Matthias Siepe · 2019 · European Journal of Cardio-Thoracic Surgery
38. Predicting sudden cardiac death in a general population using an electrocardiographic risk score
    Arttu Holkeri, Antti Eranti, Mira Anette E. Haukilahti, Tuomas V. Kerola, Tuomas V Kenttä, Jani T. Tikkanen, Olli M. Anttonen, Kai Noponen, Tapio Seppänen, Harri A. Rissanen et al. · 2019 · Heart
39. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study
    Axel Bauer, Mathias Klemm, Konstantinos D. Rizas, Wolfgang Hamm, Lukas von Stülpnagel, Michael Dommasch, Alexander Steger, Andrezej Lubinski, Panagiota Flevari, Markus Harden et al. · 2019 · The Lancet
40. The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
    Anne G. Raafs, Job A.J. Verdonschot, Michiel T.H.M. Henkens, Bouke P. Adriaans, Ping Wang, Kasper Derks, Myrurgia A. Abdul Hamid, Christian Knackstedt, Vanessa P. M. van Empel, Javier Dı́ez et al. · 2021 · European Journal of Heart Failure
41. Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy
    Wensu Chen, Wen Qian, Xinwei Zhang, Dongcheng Li, Zhiyong Qian, Hai Xu, Shengen Liao, Xing Chen, Yao Wang, Xiaofeng Hou et al. · 2021 · European Heart Journal - Cardiovascular Imaging
42. Signal‐averaged electrocardiography: Past, present, and future
    Konstantinos A. Gatzoulis, Πέτρος Αρσένος, Konstantinos Trachanas, Polychronis Dilaveris, Christos Konstantinos Antoniou, Dimitris Tsiachris, Skevos K. Sideris, Theofilos M. Kolettis, Dimitrios M. Tousoulis · 2018 · Journal of Arrhythmia
43. CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry
    Andrea Igoren Guaricci, Pier Giorgio Masci, Giuseppe Muscogiuri, Marco Guglielmo, Andrea Baggiano, Laura Fusini, Valentina Lorenzoni, Chiara Martini, Daniele Andreini, Anna Giulia Pavon et al. · 2020 · EP Europace
44. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology
    Camilla Normand, David M. Kaye, Thomas Joseph Povsic, Kenneth Dickstein · 2019 · The Lancet
45. Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy
    Katja Zeppenfeld · 2018 · JACC. Clinical electrophysiology
46. Nuclear Imaging of the Cardiac Sympathetic Nervous System
    Jason G.E. Zelt, Robert A. deKemp, Benjamin H. Rotstein, Girish M. Nair, Jagat Narula, Ali Reza Ahmadi, Rob S. Beanlands, Lisa Marie Mielniczuk · 2019 · JACC. Cardiovascular imaging
47. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy
    Mahesh Anantha Narayanan, Kairav P. Vakil, Yogesh N.V. Reddy, Janani Baskaran, Abhishek J. Deshmukh, David G. Benditt, Selçuk Adabağ · 2017 · JACC. Clinical electrophysiology
48. Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure
    Ankur Gulati, Alan G. Japp, Sadaf Raza, Brian P. Halliday, Daniel A. Jones, Simon Newsome, Nizar A. Ismail, Kishen Morarji, Jahanzaib Khwaja, Nick B. Spath et al. · 2018 · Circulation Cardiovascular Imaging
49. The Treatment of Heart Failure with Reduced Ejection Fraction
    Dominik Berliner, Anja Hänselmann, Johann K Bauersachs · 2020 · Deutsches Ärzteblatt international
50. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death
    Ahmad Masri, Ahmed M. A. Altibi, Sebhat A. Erqou, Mohammad A. Zmaili, A Mohamed Saleh, Raed Al-Adham, Karam F. Ayoub, Moaaz Baghal, Laith Alkukhun, Amr F. Barakat et al. · 2019 · JACC. Clinical electrophysiology
51. Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging
    Christian Eichhorn, David Koeckerling, Rohin K. Reddy, Maddalena Ardissino, Marek Rogowski, Bernadette Coles, Lukas Hunziker, Simon Greulich, Isaac Shiri, Norbert Frey et al. · 2024 · JAMA
52. Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators
    Ben Corden, Julian W.E. Jarman, Nicola Whiffin, Upasana Tayal, Rachel J. Buchan, Joban Sehmi, Andrew Robert Harper, William Midwinter, Karen Lascelles, Vias Markides et al. · 2019 · JAMA Network Open
53. Systematic review for the 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    Fred M Kusumoto, Kent R. Bailey, Ahmad Sami Chaouki, Abhishek J. Deshmukh, Sandeep Gautam, Robert J. Kim, Daniel Bruce Kramer, Litsa Konstance Lambrakos, Naseer H. Nasser, Dan Sorajja · 2017 · Heart Rhythm
54. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy
    Andrea Barison, Alberto Aimo, Alessandro Ortalda, Giancarlo Todiere, Chrysanthos Grigoratos, Claudio Passino, Paolo Guido Camici, Giovanni Donato Aquaro, Michele Emdin · 2017 · International Journal of Cardiology
55. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction
    Jesse F. Veenis, Hans‐Peter Brunner‐La Rocca, Gerard C.M. Linssen, Peter R Geerlings, Marco W.F. van Gent, Ismail Aksoy, Liane Oosterom, Arno H. Moons, Arno Wilhelmus Hoes, Jasper Jan Brugts et al. · 2019 · European Journal of Preventive Cardiology
56. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator
    Neal A. Chatterjee, Rasmus Borgquist, Yuchiao Chang, Jennifer Lewey, Vicki Ann Jackson, Jagmeet P. Singh, Joshua P. Metlay, Charlotta J. Lindvall · 2016 · European Heart Journal
57. Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure—DANISH-MRI
    Marie Bayer Elming, Sophia Hammer‐Hansen, Inga Voges, Eva G. Nyktari, Anna Axelsson Raja, Jesper Hastrup Svendsen, Steen Michael Pehrson, James Signorovitch, Lars Køber, Sanjay Kumar Prasad et al. · 2019 · American Heart Journal
58. Left ventricular hypertrophy and sudden cardiac death
    Grigorios Giamouzis, Apostolos K Dimos, Andrew V. Xanthopoulos, John S. Skoularigis, Filippos K. Triposkiadis · 2021 · Heart Failure Reviews
59. JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
    Yu‐ki Iwasaki, Takashi Noda, Masaharu Akao, Tadashi Fujino, Teruyuki Hirano, Koichi Inoue, KENGO FUKUSHIMA KUSANO, Toshiyuki Nagai, Kazuhiro Satomi, Tetsuji Shinohara et al. · 2025 · Circulation Journal
60. 2026 ESC Guidelines for the management of heart failure
    Lars Køber, Marianna Adamo, Anne‐Christine Ruwald, Daniela Tomasoni, Lisa Anderson, Charlotte Andersson, Jasper Jan Brugts, Ovidiu Dragomir Chioncel, Erwan Donal, Péter Ferdinandy et al. · 2026 · European Heart Journal
61. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention
    Rahul G. Muthalaly, Raymond Y.K. Kwong, Roy M. John, Rob J. van der Geest, Qian Tao, Benjamin N. Schaeffer, Shin‐ichi Tanigawa, Tomofumi Nakamura, Kyoichi Kaneko, Usha B. Tedrow et al. · 2018 · JACC. Cardiovascular imaging
62. Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy
    Michalina Marta Kołodziejczak, Felicita Andreotti, Mariusz Kowalewski, Antonino Buffon, Marco Matteo Ciccone, Gianfranco Parati, Pietro Scicchitano, Julia Maria Umińska, Stefano De Servi, Kevin P. Bliden et al. · 2017 · Annals of Internal Medicine
63. EHRA White Paper: knowledge gaps in arrhythmia management—status 2019
    Andreas Goette, Angelo Auricchio, Giuseppe Boriani, Frieder Braunschweig, Josép Brugada, Haran Burri, A. John Camm, Harry J.G.M. Crijns, Nikolaos Dagres, Jean‐Claude Deharo et al. · 2019 · EP Europace
64. Cardiac Implantable Electronic Device Therapy in Heart Failure
    Ayman Ali Hussein, Bruce Larry Wilkoff · 2019 · Circulation Research
65. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care
    Wilfried Müllens, Angelo Auricchio, Pieter Martens, Klaus K. Witte, Martín Cowie, Victoria Delgado, Kenneth Dickstein, Cecilia Marianne Linde, Kevin Vernooy, Francisco Leyva et al. · 2020 · EP Europace
66. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018
    John James Atherton, Andrew Paul Sindone, Carmine G. De Pasquale, Andrea L Driscoll, Peter Simon Macdonald, Ingrid Hopper, Peter M. Kistler, Tom G. Briffa, James Wong, Walter P. Abhayaratna et al. · 2018 · The Medical Journal of Australia
67. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta‐Analysis of Randomized Controlled Trials
    Stavros Stavrakis, Zain Ul Abideen Asad, DWIGHT W. REYNOLDS · 2017 · Journal of Cardiovascular Electrophysiology
68. Arrhythmias in Female Patients: Incidence, Presentation and Management
    Emily P. Zeitler, Jeanne E. Poole, Christine M. Albert, Sana M. Al-Khatib, Fatima Ali-Ahmed, Ulrika Birgersdotter-Green, Yong-Mei Cha, Mina K. Chung, Anne B. Curtis, Jodie L. Hurwitz et al. · 2022 · Circulation Research
69. Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
    Shu-Yang ZHANG · 2025 · 老年心脏病学杂志：英文版
70. Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction
    Neal A. Chatterjee, M. Vinayaga Moorthy, Julie Pester, Andi Schaecter, Gopi Krishna Panicker, Dhiraj D. Narula, Daniel C. Lee, Jeffrey J. Goldberger, Alan Howard Kadish, Nancy R. Cook et al. · 2018 · JAMA Cardiology
71. Prognostic nutritional index as the predictor of long‐term mortality among HFrEF patients with ICD
    Göksel Çinier, Mert İlker Hayıroğlu, Levent Pay, Ahmet Çağdaş Yumurtaş, Ozan Tezen, Semih Eren, Zeynep Kolak, Tuğba Çetin, Kazım Serhan Özcan, Ceyhan Türkkan et al. · 2021 · Pacing and Clinical Electrophysiology
72. Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project
    Moritz Hadwiger, Nikolaos Dagres, Janina Haug, Michael S. Wolf, Ursula Marschall, Jan G.P. Tijssen, Alexander Katalinic, Fabian‐Simon Frielitz, Gerhard Hindricks · 2022 · European Heart Journal
73. Contemporary trends in cardiac electrophysiology procedures in the United States, and impact of a global pandemic
    Monte Scott, Tina Baykaner, Thomas Jared Bunch, Jonathan Paul Piccini, Andrea M. Russo, Wendy S. Tzou, Emily P. Zeitler, Benjamin Adam Steinberg · 2022 · Heart Rhythm O2
74. The Vulnerable Phase of Heart Failure
    Ely A. Gracia, Prabhjot Singh, Sean P. Collins, Ovidiu Chioncel, Peter S. Pang, Javed Butler · 2018 · American Journal of Therapeutics
75. Sudden cardiac death: an update
    Julia C. Isbister, Christopher Semsarian · 2019 · Internal Medicine Journal
76. Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations
    Federico Vancheri, Giovanni Longo, Michael Y. Henein · 2024 · Frontiers in Cardiovascular Medicine
77. Time trends in sudden cardiac death risk in heart failure patients with cardiac resynchronization therapy: a systematic review
    Sérgio Barra, Rui Andre Providencia, Kumar Narayanan, Serge Bovéda, Rudolf Martin Duehmke, Rodrigue Garcia, Francisco Leyva, Veronique Lee Roger, Xavier Jouven, Sharad Agarwal et al. · 2019 · European Heart Journal
78. Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease
    Neal A. Chatterjee, Jani T. Tikkanen, Gopi Krishna Panicker, Dhiraj D. Narula, Daniel C. Lee, Tuomas V Kenttä, Juhani M. Junttila, Nancy R. Cook, Alan Howard Kadish, Jeffrey J. Goldberger et al. · 2020 · European Heart Journal
79. Ischemic Cardiomyopathy versus Non-Ischemic Dilated Cardiomyopathy in Patients with Reduced Ejection Fraction— Clinical Characteristics and Prognosis Depending on Heart Failure Etiology (Data from European Society of Cardiology Heart Failure Registries)
    Agata Tymińska, Krzysztof Ozierański, Paweł Balsam, Cezary Maciejewski, Anna Wancerz, Emil Brociek, Michał Marchel, María G. Crespo‐Leiro, Aldo Pietro Maggioni, Jarosław Dróżdż et al. · 2022 · Biology
80. Management of Ventricular Arrhythmias Worldwide
    Hilke Könemann, Christian Ellermann, Katja Zeppenfeld, Lars Eckardt · 2023 · JACC. Clinical electrophysiology
81. Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
    Fred M Kusumoto, Kent R. Bailey, Ahmad Sami Chaouki, Abhishek J. Deshmukh, Sandeep Gautam, Robert J. Kim, Daniel Bruce Kramer, Litsa Konstance Lambrakos, Naseer H. Nasser, Dan Sorajja · 2017 · Journal of the American College of Cardiology
82. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy
    Kyohei Marume, Teruo Noguchi, Emi Tateishi, Yoshiaki Morita, Tsukasa Kamakura, Kohei Ishibashi, Takashi Noda, Hiroyuki Miura, Kunihiro Nishimura, Michikazu Nakai et al. · 2018 · Circulation Arrhythmia and Electrophysiology
83. Right Ventricular Dysfunction and Long-Term Risk of Sudden Cardiac Death in Patients With and Without Severe Left Ventricular Dysfunction
    Niyada Naksuk, Nicholas Yick Loong Tan, Deepak Padmanabhan, Krishna Kancharla, Nayani Makkar, Vidhushei Yogeswaran, Prakriti Gaba, Pranita Kaginele, David C. Riley, Alan M. Sugrue et al. · 2018 · Circulation Arrhythmia and Electrophysiology
84. Electrocardiographic associations with myocardial fibrosis among sudden cardiac death victims
    Lauri T. A. Holmström, Mira Anette E. Haukilahti, Juha H. Vähätalo, Tuomas V Kenttä, Henrik Appel, Antti M. Kiviniemi, Lasse Pakanen, Heikki V. Huikuri, Robert J. Myerburg, Juhani M. Junttila · 2020 · Heart
85. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias
    Kolk, Maarten Z. H., Ruipérez-Campillo, Samuel, Allaart, Cornelis P., Wilde, Arthur A. M., Knops, Reinoud E., Narayan, Sanjiv M., Tjong, Fleur V. Y., DEEP RISK investigators, Raijmakers, Femke D., Van Der Lingen, Anne-Lotte C. J. et al. · 2024 · Scientific Reports
86. The Genetic Landscape of Cardiomyopathies
    Brenda Gerull, Sabine Klaassen, Andreas Brodehl · 2019 · Cardiac and vascular biology
87. Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF
    James P. Curtain, Alice M. Jackson, Li Shen, Pardeep S. Jhund, Kieran F. Docherty, Mark Colquhoun Petrie, Davide Castagno, Akshay Suvas Desai, Luís Eduardo Paim Rohde, Martin P. Lefkowitz et al. · 2021 · European Journal of Heart Failure
88. Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China
    Fanqi Meng, Zhihua Zhang, Xiaofeng Hou, Zhiyong Qian, Yao Wang, Yanhong Chen, Yilian Wang, Zhou Ye, Zhen Chen, Xiwen Zhang et al. · 2019 · BMJ Open
89. Improvement in Left Ventricular Ejection Fraction in Outpatients With Heart Failure With Reduced Ejection Fraction
    Adam D. DeVore, Anne S. Hellkamp, Laine Elliott Thomas, Nancy M. Albert, Javed Butler, James Herbert Patterson, John A. Spertus, Fredonia B. Williams, Carol I. Duffy, Adrian F. Hernandez et al. · 2020 · Circulation Heart Failure
90. Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy
    Craig R. Narins, Mehmet K. Aktaş, Anita Y. Chen, Scott A McNitt, Fred S. Ling, Arwa Younis, Wojciech Zaręba, James P. Daubert, David Tsu-Chau Huang, Spencer Z. Rosero et al. · 2021 · JACC. Clinical electrophysiology
91. Prediction of sudden cardiac death using artificial intelligence: Current status and future directions
    Maarten Z H Kolk, Samuel Ruipérez-Campillo, Arthur A.M. Wilde, Reinoud E. Knops, Sanjiv M. Narayan, Fleur V.Y. Tjong · 2024 · Heart Rhythm
92. Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
    Trygve S. Hall, Thomas G. von Lueder, Faiez M. Zannad, Patrick Rossignol, Kévin Duarte, Tahar Chouihed, Kenneth Dickstein, Dan Atar, Stefan Agewall, Nicolas Girerd · 2018 · International Journal of Cardiology
93. 2019 HRS / EHRA / APHRS / LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
    Edmond M. Cronin, Frank Matthias Bogun, Philippe Maury, Petr Peichl, Minglong Chen, Narayanan Namboodiri, Luis Aguinaga, Luiz Roberto Leite, Sana M. Al‐Khatib, Elad Anter et al. · 2019 · Journal of Arrhythmia
94. New perspectives and future directions in the treatment of heart failure
    Pierpaolo Pellicori, Muhammad Javed Khan, Fraser John Graham, John G.F. Cleland · 2019 · Heart Failure Reviews
95. Focused Update of 2016 Korean Society of Heart Failure Guidelines for the Management of Chronic Heart Failure
    Kyung-Jin Kim, Hyun‐Jai Cho, Min‐Seok Kim, Jeehoon Kang, Kyung‐Hee Kim, Darea Kim, Suk Min Seo, Jeong Hoon Yang, Myung‐Jin Cha, Jong‐Il Choi et al. · 2019 · International Journal of Heart Failure
96. Myocardial mechanics in dilated cardiomyopathy: prognostic value of left ventricular torsion and strain
    Andreas Ochs, Johannes H. Riffel, Marco M. Ochs, Nisha Arenja, Thomas Fritz, Christian Galuschky, Andreas Schuster, Oliver Bruder, Heiko Mahrholdt, Evangelos Giannitsis et al. · 2021 · Journal of Cardiovascular Magnetic Resonance
97. Improved prediction of sudden cardiac death in patients with heart failure through digital processing of electrocardiography
    Yasuyuki Shiraishi, Shinichi Goto, Nozomi Niimi, Yoshinori Katsumata, Ayumi Goda, Makoto Takei, Mike Saji, Motoaki Sano, Keiichi Fukuda, Takashi Kohno et al. · 2022 · EP Europace
98. JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
    Takeshi Kitai, Shun Kohsaka, Takao Kato, Eri Toda Kato, Kimi Sato, KANAKO TERAMOTO, Hidenori Yaku, Eiichi Akiyama, Masahiko Ando, Chisato Izumi et al. · 2025 · Journal of Cardiac Failure
99. Incidence and costs of cardiac device infections: retrospective analysis using German health claims data
    Saskia Ludwig, Cathrin Theis, Ben Brown, Andreas Witthohn, Wolfram Lux, Andreas Goette · 2017 · Journal of Comparative Effectiveness Research
100. Predicting Sustained Ventricular Arrhythmias in Dilated Cardiomyopathy: A Meta-Analysis and Systematic Review
     Arjan Sammani, Elham Kayvanpour, Laurens P. Bosman, Farbod Sedaghat‐Hamedani, Tanja Proctor, Weng‐Tein Gi, Alicia Broezel, Katrin Jensen, Hugo Albert Katus, Anneline S.J.M. te Riele et al. · 2020 · ESC Heart Failure